Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our June issue of Pharmaceutical Executive
FEATURES

Pharma 50
 Pharm Exec’s Top 50 Companies
William Looney
Pharm Exec’s 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
Pharma 50
Diversity and Inclusion: A Pharma 50 Perspective
Waseem Noor, Saule Serikova
Biopharma’s diversity commitment remains a work in progress but the benefits—in measurable ROI—are increasingly clear.
Discussion
 Market Access in Europe: Building Better Health Outcomes
 BCG Market Access Roundtable Working Group
A new industry working group explores alternative drug funding options in Europe—and asks key stakeholders in the region to join the discussion.
Event
 Cancer’s Disruptive Dozen
 Casey McDonald
The World Medical Innovation Forum presents its second list of breakthrough technologies—this time focused on oncology.
Technology
 Science Meets Art: Mapping the Topography of MS
 William Looney
A new educational and potential prognosis tool for the treatment of multiple sclerosis shows how an accessible, easy-to-see visualization of disease state can serve as the threshold for fresh clinical insight—all geared to the individual patient.
ALSO IN THIS ISSUE
 A Digital Prescription for the Pharma Industry
Michael Kunst, Ashish Singh, Grace Shieh, Simon Kennedy
How companies can better integrate valuable data across business functions to meet rising value-chain demands.

 Promises and Pitfalls in Calculating Drug Value
Jill Wechsler
There's a stampede to relate prices to broader health benefits, but little consensus on how to do so.

Pharma and Biotech Financial Outlook: Hazy
Peter Young
Do recent trends in the pharma and biotech M&A and equity markets signal a temporary lull — or a permanent drop?
 
WEBCASTS
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
A Radical PLC Pricing Model to Break the Circle of Distrust
Understanding the Chronic Disease Patient Journey in Emerging Markets
Precision Asset Valuation: Leveraging Insights from Clinical and Market Access Big Data
 
Download the
issue:
 
image

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn